Bottom line
GSIMX vs MRSAX: the short answer
GSIMX (Goldman Sachs GQG Partners International Opportunities Fund) and MRSAX (MFS Research International Fund) are both mutual funds.
GSIMX is cheaper at 0.78% vs 0.99% — a difference of $21 a year per $10,000 invested.
Over five years, GSIMX returned +9.2% a year vs +2.6% for MRSAX (reporting dates differ).
MRSAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
GSIMX vs MRSAX side by side
| GSIMX | MRSAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Goldman Sachs | MFS |
| Category | International Stock | International Stock |
| Expense ratio | 0.78% | 0.99% |
| Annual cost per $10k | $78 | $99 |
| 10-yr cost on $10k (prospectus) | $988 | $1,728 |
| Max front load | 0% | 5.75% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +20.8% | −3.1% |
| 5-yr return (annualized) | +9.2% | +2.6% |
| 10-yr return (annualized) | — | +4.5% |
| Best quarter | +17.5% | +16.5% |
| Worst quarter | −13.6% | −19.7% |
| Net assets (fund) | $54.1B | $17.8B |
| Number of holdings | 74 | 121 |
| Portfolio turnover | 68% | 27% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GSIMX | MRSAX | Difference |
|---|---|---|---|
| 2024 | +6.0% | +2.9% | +3.1% |
| 2023 | +22.2% | +13.1% | +9.0% |
| 2022 | −11.1% | −17.5% | +6.4% |
| 2021 | +12.5% | +11.6% | +0.9% |
| 2020 | +15.7% | +12.9% | +2.8% |
| 2019 | +27.6% | +27.7% | −0.0% |
| 2018 | −6.0% | −14.2% | +8.2% |
| 2017 | +31.8% | +28.1% | +3.7% |
Source: Fund prospectus bar charts
Holdings overlap
6 of GSIMX's top 25 holdings also appear in MRSAX's top 25.
| Holding | GSIMX | MRSAX |
|---|---|---|
| TotalEnergies SE | 4.64% | 2.10% |
| British American Tobacco PLC | 4.46% | 1.44% |
| Novartis AG | 3.52% | 2.12% |
| AstraZeneca PLC | 2.82% | 1.78% |
| Taiwan Semiconductor Manufacturing Co Ltd | 1.85% | 2.21% |
| ASML Holding NV | 1.56% | 2.21% |
Source: SEC Form N-PORT
GSIMX top 10
- Philip Morris International Inc — 6.57%
- TotalEnergies SE — 4.64%
- Chubb Ltd — 4.60%
- British American Tobacco PLC — 4.46%
- Goldman Sachs Financial Square Government Fund — 3.66%
- Novartis AG — 3.52%
- Iberdrola SA — 3.45%
- AstraZeneca PLC — 2.82%
- Enbridge Inc — 2.71%
- Enel SpA — 2.60%
MRSAX top 10
- Mizuho Financial Group Inc — 2.90%
- Schneider Electric SE — 2.82%
- Hitachi Ltd — 2.45%
- ASML Holding NV — 2.21%
- Taiwan Semiconductor Manufacturing Co Ltd — 2.21%
- Novartis AG — 2.12%
- TotalEnergies SE — 2.10%
- Tokyo Electron Ltd — 1.90%
- AstraZeneca PLC — 1.78%
- Linde PLC — 1.76%
FAQ
What is the difference between GSIMX and MRSAX?
Which is cheaper, GSIMX or MRSAX?
Should I own both GSIMX and MRSAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.